Advances in Hematopoietic Stem Cell Research and Their Applications in Disease Therapy

Hematopoietic stem cells (HSCs) serve a critical role in maintaining the immune system and hematological homeostasis. Through their unique capacity for both self-renewal and multilineage differentiation, HSCs give rise to all blood cell types. The dysregulation of HSC function is closely linked to the pathogenesis of various hematologic disorders. Thus, this paper examines the role of HSCs in acute lymphoblastic leukemia, sickle cell disease, and aplastic anemia, highlighting their significance in disease development and therapeutic approaches. Furthermore, current therapeutic strategies, including cell transplantation and gene editing techniques, are reviewed by analyzing relevant literature, and their advantages, limitations and future directions of these approaches are discussed. The results suggest that despite the progress made in current therapeutic approaches, challenges persist, especially in terms of immune rejection and durability of treatment response. These issues hinder the long-term effectiveness of therapies, as immune resistance can cause graft failure or relapse, and the durability of therapeutic benefits remains a major concern for patient outcomes. As such, future research should optimize treatment options, overcome the limitations of current technologies, and enhance clinical outcomes.